Fig. L-1.jpg (0.6 mg)
A small dosage of 0.6 milligrams has been chosen or prescribed for a specific purpose, such as medication or treatment.*
Liraglutide Injection
Product Images NDC 70377-094
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Liraglutide (NDC 70377-094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Biocon Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig. L-2.jpeg (1.2 mg)
This text specifies the selection of 1.2 mg of a substance or medication.*
Fig. L-3.jpg (1.8mg)
This text contains information about a selected quantity of 1.8 milligrams. It may refer to a specific amount of a substance or medication.*
Liraglutide Injection Carton 2-pens (2 Pens)
This is information about Liraglutide injection, available in a pack of 2 pens delivering doses of 0.6 mg, 1.2 mg, or 1.8 mg. It is for subcutaneous use only and for single-patient use. Pen needles are not included, and each pen should be discarded 30 days after first use. The medication should be refrigerated and not frozen. Patients should be given a medication guide. This product is prescription-only and comes with specific identification numbers and expiration date. The text also mentions that the pens contain 18 mg/3 mL (6 mg/mL) of Liraglutide.*
Liraglutide Injection Carton 3-pens (3 Pens)
This text contains information about a medication called Liraglutide in the form of an injection. The medication comes in a package of 3 pens, with each pen delivering doses of 0.6 mg, 1.2 mg, or 1.8 mg for subcutaneous use only. It is indicated for single patient use only. The medication guide should be dispensed to each patient, and pen needles are not included. It is advised to discard the pen 30 days after the first use and to store it in the refrigerator without freezing. The text also provides details such as the NDC number, expiration date, and lot number of the product.*
Figure 1: Structural Formula Of Liraglutide (49f302f5 F315 48b8 83a4 6ca56f01fded 01)
Figure 2 Mean Insulin Secretion Rate (isr) Versus Glucose Concentration (49f302f5 F315 48b8 83a4 6ca56f01fded 02)
Figure 4 Mean Hba1c For Patients Who Completed The 26-week Trial And For The Last Observation Carried Forward (locf, Intent-to-treat) Data At Week 26 (49f302f5 F315 48b8 83a4 6ca56f01fded 04)
Figure-5 (Figure 5)
Figure-d (Figure D)
Figure K (Figure K)
Victoza Pen And Needle (Image 01)
This text appears to be a description of a Liraglutide Injection Pen. The pen includes features such as a cartridge tip, dose selector button, and a needle for injection. It also provides a toll-free hotline for users experiencing problems with the pen.*
Fig. A (Pull off pen cap)
Fig. B (Remove protective tab.)
Fig. C (Image 04)
Fig. E (Image 05)
Fig. F (Image 06)
Fig. G (Image 07)
Fig. H (Image 08)
Fig. I (Image 09)
Fig. J (Image 10)
Fig. L (Image 11)
Fig. M (Image 12)
Fig. N (Image 13)
Fig. O (Image 14)
Fig. P (Image 15)
Fig. Q (Image 16)
Figure 3 (Image 21)
Image-r (Image R)
Image-jpeg (Symbol)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
